ORGANIZATION

JGA Takes Sincerely 50% Pricing Rule for First Generics, There’s Limitation to Data Collection: Chief

January 13, 2016

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The generic industry will “take sincerely” a new 50% pricing rule to be rolled out this year, which will price first generics at 50% of their original drug prices, Itsuro Yoshida, president of Japan Generic Medicines Association (JGA), said in…

To read the full story

Generic Industry’s Tactic to Thwart 50% Pricing Rule Draws Mixed Reviews
January 18, 2016

ORGANIZATION

Boehringer’s Hasson Appointed EFPIA Japan Vice Chair
June 22, 2026
Think Tank Opposes Cap on Social Security Burden Ratio, Urges Pause in Off-Year Price Cuts
June 22, 2026
Japanese Drug Makers Step Up Use of ASEAN Reliance Reviews
June 18, 2026
Ease Foreign Price Adjustment Rules for New Drugs to Counter MFN Policy: FPMAJ
June 15, 2026
Raise Foreign Price Adjustment Cap for Listed Products in German Cases: FPMAJ
June 15, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…

COLUMN

More Positions, More Candidates: A Snapshot of Movement in Japan’s Pharma Industry

By Philip Carrigan

Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…